What's New Wednesday — Integrated Psych

What’s New Wednesday

Psychiatric illnesses share common brain network.
Positive results for novel psychedelic in Major Depression.
The U.S. Surgeon General says 13 years old is too young to begin using social media.
Lipid signature may flag Schizophrenia and other mental health illnesses.
Monitoring and treating depressive symptoms in young adults may help promote brain health in midlife and older age.
New drug for MDD and Postpartum Depression, Zuranolone, is set for FDA priority approval August 2023.
Repetitive TMS is associated with increased abstinence in substance use disorders and comorbid depression.
Swedish researchers find OCD transmitted from parents to children largely through a genetic relationship.
Mitochondrial deterioration linked to Major Depression in older adults.
Neuroscientists learn why PTSD patients relive highly charged fear memories in sleep.
Scientists “switch off” autism in mice using $3 epilepsy drug.
Study suggests vasodilator drugs may be new therapeutic approach to the treatment of schizophrenia.
Bright light therapy shows effectiveness when combined with therapeutic treatment for bipolar depression.
Blood test for anxiety developed.
People with symptoms of depression may have an increased risk of stroke.
Once-daily stimulant for ADHD safe and effective at one year.

Every Wednesday, our Clinical Research team shares some of the news and advances that relate to mental health. You can also find links to these news stories in the What’s New Wednesday Highlight on our Instagram.